Your session is about to expire
← Back to Search
Autologous bone marrow aspirate will be harvested and concentrated to a bone marrow aspirate concentrate (BMAC) containing bone marrow derived mesenchymal stem cells and delivered to site of operation for Cartilage Injury
Study Summary
This trial is testing whether a stem cell injection improves joint function after an osteochondral allograft (a joint replacement).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many trial participants are currently enrolled in this experiment?
"Affirmative. Clinicaltrials.gov has the latest information on this trial, which was initially posted on March 2nd 2018 and recently modified in February 2022. 40 participants are being recruited from a single medical centre for participation."
Does the protocol for this investigation extend to individuals over twenty years old?
"The preliminary enrolment criteria for this clinical trial is a patient age range between 18 and 50 years old."
To what demographic of participants does this clinical trial apply?
"Eligible candidates for this clinical trial will be between 18 and 50 years old with a history of cartilage injury. The medical study is looking to recruit approximately 40 participants."
Are any additional participants able to join this trial?
"This research study is seeking participants as per the data hosted on clinicaltrials.gov, which was initially posted in March 2018 and amended most recently in February 2022."
Share this study with friends
Copy Link
Messenger